Cardiovascular Research - Immunity and Atherosclerosis
21 – 30 of 550
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Novel oral anticoagulant use in adults with congenital heart disease : a single-center experience report
(
- Contribution to journal › Article
-
Mark
Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
(
- Contribution to journal › Article
-
Mark
A pharmacoproteomic landscape of organotypic intervention responses in Gram-negative sepsis
(
- Contribution to journal › Article
-
Mark
Increased cesarean section rate and premature birth according to modified WHO maternal cardiovascular risk in pregnant women with congenital heart disease
(
- Contribution to journal › Article
-
Mark
Editorial : Aortopathy in congenital heart disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
-
Mark
Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
(
- Contribution to journal › Article
-
Mark
Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk
(
- Contribution to journal › Article
-
Mark
Evidence for Impaired Renin Activity in Postural Orthostatic Tachycardia Syndrome
(
- Contribution to journal › Article
-
Mark
Ablation of GPR56 Causes β-Cell Dysfunction by ATP Loss through Mistargeting of Mitochondrial VDAC1 to the Plasma Membrane
(
- Contribution to journal › Article